Literature DB >> 12525618

Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriers.

Diane Sitki-Green1, Mary Covington, Nancy Raab-Traub.   

Abstract

Infection with the Epstein-Barr virus (EBV) is often subclinical in the presence of a healthy immune response; thus, asymptomatic infection is largely uncharacterized. This study analyzed the nature of EBV infection in 20 asymptomatic immunocompetent hosts over time through the identification of EBV strain variants in the peripheral blood and oral cavity. A heteroduplex tracking assay specific for the EBV gene LMP1 precisely identified the presence of multiple EBV strains in each subject. The strains present in the peripheral blood and oral cavity were often completely discordant, indicating the existence of distinct infections, and the strains present and their relative abundance changed considerably between time points. The possible transmission of strains between the oral cavity and peripheral blood compartments could be tracked within subjects, suggesting that reactivation in the oral cavity and subsequent reinfection of B lymphocytes that reenter the periphery contribute to the maintenance of persistence. In addition, distinct virus strains persisted in the oral cavity over many time points, suggesting an important role for epithelial cells in the maintenance of persistence. Asymptomatic individuals without tonsillar tissue, which is believed to be an important source of virus for the oral cavity, also exhibited multiple strains and a cyclic pattern of transmission between compartments. This study revealed that the majority of patients with infectious mononucleosis were infected with multiple strains of EBV that were also compartmentalized, suggesting that primary infection involves the transmission of multiple strains. Both the primary and carrier states of infection with EBV are more complex than previously thought.

Entities:  

Mesh:

Year:  2003        PMID: 12525618      PMCID: PMC140987          DOI: 10.1128/jvi.77.3.1840-1847.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  EBV persistence in memory B cells in vivo.

Authors:  G J Babcock; L L Decker; M Volk; D A Thorley-Lawson
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

2.  Tissue distribution of Epstein-Barr virus genotypes.

Authors:  H L Chen; M L Lung; K H Chan; B E Griffin; M H Ng
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

3.  A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.

Authors:  L C Tan; N Gudgeon; N E Annels; P Hansasuta; C A O'Callaghan; S Rowland-Jones; A J McMichael; A B Rickinson; M F Callan
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

4.  Sequence variation of latent membrane protein-1 of Epstein-Barr virus strains associated with hairy leukoplakia.

Authors:  J M Palefsky; J Berline; M E Penaranda; E T Lennette; D Greenspan; J S Greenspan
Journal:  J Infect Dis       Date:  1996-03       Impact factor: 5.226

5.  Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals.

Authors:  Q Y Yao; R J Tierney; D Croom-Carter; D Dukers; G M Cooper; C J Ellis; M Rowe; A B Rickinson
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China.

Authors:  N S Sung; R H Edwards; F Seillier-Moiseiwitsch; A G Perkins; Y Zeng; N Raab-Traub
Journal:  Int J Cancer       Date:  1998-04-13       Impact factor: 7.396

7.  Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells.

Authors:  X Wang; W J Kenyon; Q Li; J Müllberg; L M Hutt-Fletcher
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification.

Authors:  C Berger; D van Baarle; M J Kersten; M R Klein; A S Al-Homsi; B Dunn; C McQuain; R van Oers; H Knecht
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

9.  Characterization of the viral population during primary HIV-1 infection.

Authors:  A C Karlsson; S Lindbäck; H Gaines; A Sönnerborg
Journal:  AIDS       Date:  1998-05-28       Impact factor: 4.177

10.  Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.

Authors:  N M Steven; N E Annels; A Kumar; A M Leese; M G Kurilla; A B Rickinson
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

View more
  54 in total

1.  LMP1 strain variants: biological and molecular properties.

Authors:  Bernardo A Mainou; Nancy Raab-Traub
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups.

Authors:  Laura R Wasil; Kathy H Y Shair
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

3.  Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology.

Authors:  Pan Liu; Xiaodong Fang; Zizhen Feng; Yun-Miao Guo; Rou-Jun Peng; Tengfei Liu; Zhiyong Huang; Yue Feng; Xiaoqing Sun; Zhiqiang Xiong; Xiaosen Guo; Sha-Sha Pang; Bo Wang; Xiaojuan Lv; Fu-Tuo Feng; Da-Jiang Li; Li-Zhen Chen; Qi-Sheng Feng; Wen-Lin Huang; Mu-Sheng Zeng; Jin-Xin Bei; Yong Zhang; Yi-Xin Zeng
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

4.  Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism.

Authors:  Xiaoping Sun; Elizabeth A Barlow; Shidong Ma; Stacy R Hagemeier; Sarah J Duellman; Richard R Burgess; Judy Tellam; Rajiv Khanna; Shannon C Kenney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

5.  Epstein-Barr virus in oral shedding of children with multiple sclerosis.

Authors:  Carmen Yea; Raymond Tellier; Patrick Chong; Garrett Westmacott; Ruth Ann Marrie; Amit Bar-Or; Brenda Banwell
Journal:  Neurology       Date:  2013-09-06       Impact factor: 9.910

6.  A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.

Authors:  Adam Z Cheng; Sofia N Moraes; Claire Attarian; Jaime Yockteng-Melgar; Matthew C Jarvis; Matteo Biolatti; Ganna Galitska; Valentina Dell'Oste; Lori Frappier; Craig J Bierle; Stephen A Rice; Reuben S Harris
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

7.  Abortion in a Mediterranean miniature donkey (Equus asinus) associated with a gammaherpesvirus similar to Equid herpesvirus 7.

Authors:  Tessa E LeCuyer; Anette Rink; Daniel S Bradway; James F Evermann; Anthony V Nicola; Timothy Baszler; Gary J Haldorson
Journal:  J Vet Diagn Invest       Date:  2015-10-13       Impact factor: 1.279

8.  Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms.

Authors:  Mario Alejandro Lorenzetti; Magdalena Gantuz; Jaime Altcheh; Elena De Matteo; Paola Andrea Chabay; María Victoria Preciado
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

9.  Compartmentalization of hepatitis B virus: Looking beyond the liver.

Authors:  Sibnarayan Datta
Journal:  World J Hepatol       Date:  2015-09-18

10.  Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice.

Authors:  Laurent Gillet; Michael B Gill; Susanna Colaco; Christopher M Smith; Philip G Stevenson
Journal:  J Gen Virol       Date:  2006-12       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.